Teleflex Inc. (NYSE:TFX) – Stock analysts at Leerink Swann cut their Q3 2016 earnings estimates for shares of Teleflex in a research note issued to investors on Tuesday. Leerink Swann analyst R. Newitter now expects that the brokerage will earn $1.79 per share for the quarter, down from their prior forecast of $1.80. Leerink Swann currently has a “Market Perform” rating and a $190.00 target price on the stock. Leerink Swann also issued estimates for Teleflex’s FY2018 earnings at $8.75 EPS.
Teleflex (NYSE:TFX) last posted its earnings results on Thursday, July 28th. The medical technology company reported $1.89 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.74 by $0.15. Teleflex had a net margin of 14.89% and a return on equity of 15.59%. The firm earned $473.60 million during the quarter, compared to analysts’ expectations of $468.40 million. During the same period last year, the company posted $1.42 EPS. The company’s quarterly revenue was up 4.8% compared to the same quarter last year.
Other research analysts have also issued research reports about the company. Zacks Investment Research upgraded Teleflex from a “hold” rating to a “buy” rating and set a $192.00 price objective on the stock in a report on Wednesday, June 29th. Jefferies Group boosted their price target on shares of Teleflex from $157.00 to $185.00 and gave the company a “hold” rating in a research report on Friday, July 29th. Barclays PLC boosted their price target on shares of Teleflex from $183.00 to $185.00 and gave the company an “overweight” rating in a research report on Friday, July 29th. Finally, Raymond James Financial Inc. raised shares of Teleflex from an “outperform” rating to a “strong-buy” rating in a research report on Wednesday, June 1st. Two research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company. Teleflex currently has a consensus rating of “Buy” and a consensus price target of $171.33.
Shares of Teleflex (NYSE:TFX) traded down 0.49% on Wednesday, reaching $167.44. 118,908 shares of the company were exchanged. The company’s 50-day moving average is $180.11 and its 200-day moving average is $169.39. Teleflex has a 52 week low of $122.14 and a 52 week high of $188.79. The company has a market capitalization of $7.37 billion, a price-to-earnings ratio of 29.72 and a beta of 0.83.
The business also recently announced a quarterly dividend, which was paid on Thursday, September 15th. Shareholders of record on Monday, August 15th were given a $0.34 dividend. The ex-dividend date was Thursday, August 11th. This represents a $1.36 dividend on an annualized basis and a yield of 0.81%. Teleflex’s payout ratio is currently 24.11%.
A number of hedge funds and other institutional investors have recently bought and sold shares of TFX. Norges Bank acquired a new stake in shares of Teleflex during the fourth quarter worth about $43,143,000. Raymond James Trust N.A. raised its stake in shares of Teleflex by 3.0% in the first quarter. Raymond James Trust N.A. now owns 2,311 shares of the medical technology company’s stock worth $362,000 after buying an additional 68 shares during the period. Commonwealth Equity Services Inc raised its stake in shares of Teleflex by 4.5% in the first quarter. Commonwealth Equity Services Inc now owns 3,460 shares of the medical technology company’s stock worth $543,000 after buying an additional 150 shares during the period. Aperio Group LLC raised its stake in shares of Teleflex by 26.9% in the first quarter. Aperio Group LLC now owns 11,713 shares of the medical technology company’s stock worth $1,839,000 after buying an additional 2,481 shares during the period. Finally, Virginia Retirement System acquired a new stake in shares of Teleflex during the first quarter worth about $1,947,000. 93.77% of the stock is currently owned by institutional investors.
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company markets and sells its products to hospitals and healthcare providers, across the world, through a combination of its direct sales force and distributors.
Receive News & Ratings for Teleflex Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Inc. and related companies with MarketBeat.com's FREE daily email newsletter.